Ryosuke Negoro
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
- Oncology 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Kazuo Takayama (15 shared papers)Hiroyuki Mizuguchi (9 shared papers)Fuminori Sakurai (4 shared papers)Masashi Tachibana (2 shared papers)Kazuo Harada (3 shared papers)Kazumasa Hirata (3 shared papers)Takuya Fujita (9 shared papers)Sayaka Deguchi (9 shared papers)
- Journals
- Scientific Reports (3 papers)ACS Biomaterials Science & Engineering (2 papers)Biochemical and Biophysical Research Communications (2 papers)Biological and Pharmaceutical Bulletin (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)
- Partner nations
- Japan
In The Last Decade
Ryosuke Negoro
24 papers receiving 363 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 92
- Oncology 98
- Pharmaceutical Science 22
- Biomedical Engineering 89
- Neurology 16
Countries citing papers authored by Ryosuke Negoro
This map shows the geographic impact of Ryosuke Negoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Negoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Negoro more than expected).
Fields of papers citing papers by Ryosuke Negoro
This network shows the impact of papers produced by Ryosuke Negoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Negoro. The network helps show where Ryosuke Negoro may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Negoro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 51 | |
| 2 | 2015 | 50 | |
| 3 | 2016 | 44 | |
| 4 | 2019 | 43 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 17 | |
| 7 | 2024 | 16 | |
| 8 | 2024 | 13 | |
| 9 | 2019 | 12 | |
| 10 | 2022 | 12 | |
| 11 | 2023 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2023 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2021 | 3 |
About Ryosuke Negoro
Ryosuke Negoro is a scholar working on Pharmacology, Oncology, Biomedical Engineering, Molecular Biology and Genetics, having authored 24 papers that have together received 370 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (8 papers), Pharmacogenetics and Drug Metabolism (8 papers), 3D Printing in Biomedical Research (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Microfluidic and Capillary Electrophoresis Applications (3 papers), Mesenchymal stem cell research (2 papers), COVID-19 Clinical Research Studies (1 paper) and Glutathione Transferases and Polymorphisms (1 paper). The work is most often cited by research in Pharmacology (92 citations), Oncology (98 citations), Pharmaceutical Science (22 citations), Biomedical Engineering (89 citations) and Neurology (16 citations). Ryosuke Negoro has collaborated with scholars based in Japan. Frequent co-authors include Kazuo Takayama, Hiroyuki Mizuguchi, Fuminori Sakurai, Masashi Tachibana, Kazuo Harada, Kazumasa Hirata, Takuya Fujita, Sayaka Deguchi, Yasuhito Nagamoto and Tomoki Yamashita. Their work appears in journals such as Scientific Reports, ACS Biomaterials Science & Engineering, Biochemical and Biophysical Research Communications, Biological and Pharmaceutical Bulletin and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.